Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07531745 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 4 to 6v7
  2. Study sites: 3 to 4v6
  3. Start date changed from estimate of Apr 2026 to May 21, 2026v5
  4. Study sites: 2 to 3v4
  5. Study sites: 1 to 2v3
  6. Recruitment opened Study sites: 0 to 1v2 Show 1 more changeShow less
    • Study sites: 0 to 1
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary purpose of this study is to evaluate the safety and tolerability of ION337 in participants with Dravet syndrome (DS).
Trial Details
NCT Number NCT07531745
Lead Sponsor Ionis Pharmaceuticals, Inc.
Conditions Dravet Syndrome
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov